MODIFICATION TO BD FACSCANTO SYSTEM WITH BD FACSCANTO CLINICAL SOFTWARE— 510(k) K050191
Substantially EquivalentBecton, Dickinson & CO
FDA 510(k) clearance K050191 for MODIFICATION TO BD FACSCANTO SYSTEM WITH BD FACSCANTO CLINICAL SOFTWARE, Substantially Equivalent on 2005-02-22. Applicant: Becton, Dickinson & CO.
Clearance details
- Applicant
- Becton, Dickinson & CO
- Product code
- Code PER
- Advisory panel
- Clinical Chemistry
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Special
- Location
- San Jose, CA, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.